Microbot Medical Inc. Files 8-K for Material Agreement
Ticker: MBOT · Form: 8-K · Filed: Feb 11, 2025 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Feb 11, 2025 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.01, $2.13, $13.0 million, $25,000, $35,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
TL;DR
Microbot Medical Inc. signed a big deal, filed an 8-K on Feb 11.
AI Summary
Microbot Medical Inc. announced on February 9, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other events. This filing was made on February 11, 2025.
Why It Matters
This 8-K filing indicates a significant development for Microbot Medical Inc., potentially involving a new contract or partnership that could impact its business operations and financial future.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities, which can sometimes indicate financial strain or dilution for existing shareholders.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- February 9, 2025 (date) — Earliest event reported
- February 11, 2025 (date) — Filing date
FAQ
What is the nature of the material definitive agreement entered into by Microbot Medical Inc.?
The filing does not specify the details of the material definitive agreement, only that one was entered into on or before February 9, 2025.
What was the date of the earliest event reported in this 8-K filing?
The earliest event reported was on February 9, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed on February 11, 2025.
Does the filing provide information on Microbot Medical Inc.'s financial statements?
Yes, the filing lists 'Financial Statements and Exhibits' as an item information, suggesting financial data is included or referenced.
What other types of events are reported in this filing besides the material agreement?
The filing also reports on unregistered sales of equity securities and other events.
Filing Stats: 1,946 words · 8 min read · ~6 pages · Grade level 11.8 · Accepted 2025-02-11 09:23:54
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
- $2.13 — Common Stock"), at an offering price of $2.13 per share for aggregate gross proceeds
- $13.0 million — ngs (as defined below) of approximately $13.0 million before deducting the placement agent fe
- $25,000 — Offerings, a non-accountable expense of $25,000, up to $35,000 for its fees and expense
- $35,000 — n-accountable expense of $25,000, up to $35,000 for its fees and expenses of legal coun
- $15,950 — fees and expenses of legal counsel and $15,950 for clearing expenses. The Company has
- $2.6625 — 9, 2030), and have an exercise price of $2.6625 per share. Further, pursuant to the Eng
Filing Documents
- form8-k.htm (8-K) — 55KB
- ex4-1.htm (EX-4.1) — 118KB
- ex4-2.htm (EX-4.2) — 118KB
- ex5-1.htm (EX-5.1) — 13KB
- ex10-1.htm (EX-10.1) — 273KB
- ex99-1.htm (EX-99.1) — 15KB
- ex5-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-25-005820.txt ( ) — 890KB
- mbot-20250209.xsd (EX-101.SCH) — 3KB
- mbot-20250209_lab.xml (EX-101.LAB) — 33KB
- mbot-20250209_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. /s/ Harel Gadot Harel Gadot Chairman, President and Chief Executive Officer Date: February 11, 2025